178 related articles for article (PubMed ID: 16970993)
1. Atypical antipsychotics related metabolic syndrome in bipolar patients.
Yumru M; Savas HA; Kurt E; Kaya MC; Selek S; Savas E; Oral ET; Atagun I
J Affect Disord; 2007 Mar; 98(3):247-52. PubMed ID: 16970993
[TBL] [Abstract][Full Text] [Related]
2. Twelve-month prospective, multinational, observational study of factors associated with recovery from mania in bipolar disorder in patients treated with atypical antipsychotics.
Dikeos D; Badr MG; Yang F; Pesek MB; Fábián Z; Tapia-Paniagua G; Hudiţă C; Okasha T; D'yachkova Y; Harrison G; Treuer T
World J Biol Psychiatry; 2010 Jun; 11(4):667-76. PubMed ID: 20334575
[TBL] [Abstract][Full Text] [Related]
3. Weight gain, obesity, and metabolic indices following a first manic episode: prospective 12-month data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM).
Bond DJ; Kauer-Sant'Anna M; Lam RW; Yatham LN
J Affect Disord; 2010 Jul; 124(1-2):108-17. PubMed ID: 19914720
[TBL] [Abstract][Full Text] [Related]
4. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies.
Yatham LN; Kennedy SH; O'Donovan C; Parikh S; MacQueen G; McIntyre R; Sharma V; Silverstone P; Alda M; Baruch P; Beaulieu S; Daigneault A; Milev R; Young LT; Ravindran A; Schaffer A; Connolly M; Gorman CP;
Bipolar Disord; 2005; 7 Suppl 3():5-69. PubMed ID: 15952957
[TBL] [Abstract][Full Text] [Related]
5. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007.
Yatham LN; Kennedy SH; O'Donovan C; Parikh SV; MacQueen G; McIntyre RS; Sharma V; Beaulieu S;
Bipolar Disord; 2006 Dec; 8(6):721-39. PubMed ID: 17156158
[TBL] [Abstract][Full Text] [Related]
6. Trends in pharmacotherapy in patients referred to a bipolar specialty clinic, 2000-2011.
Hooshmand F; Miller S; Dore J; Wang PW; Hill SJ; Portillo N; Ketter TA
J Affect Disord; 2014 Feb; 155():283-7. PubMed ID: 24314912
[TBL] [Abstract][Full Text] [Related]
7. Atypical antipsychotics: newer options for mania and maintenance therapy.
Vieta E; Goikolea JM
Bipolar Disord; 2005; 7 Suppl 4():21-33. PubMed ID: 15948764
[TBL] [Abstract][Full Text] [Related]
8. Metabolic syndrome with different antipsychotics: a multicentre cross-sectional study.
Cerit C; Vural M; Bos Gelmez SÜ; Ozten E; Aker AT; Yıldız M
Psychopharmacol Bull; 2010; 43(4):22-36. PubMed ID: 21240150
[TBL] [Abstract][Full Text] [Related]
9. Adjunctive risperidone, olanzapine and quetiapine for the treatment of hospitalized patients with bipolar I disorder: a retrospective study.
Pae CU; Nassir Ghaemi S; Patkar A; Chae JH; Bahk WM; Jun TY; Masand P
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1322-5. PubMed ID: 16631294
[TBL] [Abstract][Full Text] [Related]
10. Effects of atypical antipsychotics on neurocognition in euthymic bipolar patients.
Torrent C; Martinez-Arán A; Daban C; Amann B; Balanzá-Martínez V; del Mar Bonnín C; Cruz N; Franco C; Tabarés-Seisdedos R; Vieta E
Compr Psychiatry; 2011; 52(6):613-22. PubMed ID: 21295774
[TBL] [Abstract][Full Text] [Related]
11. Long-term use of atypical antipsychotics in bipolar disorder.
Ehret MJ; Levin GM
Pharmacotherapy; 2006 Aug; 26(8):1134-47. PubMed ID: 16863489
[TBL] [Abstract][Full Text] [Related]
12. Olanzapine or lamotrigine addition to lithium in remitted bipolar disorder patients with anxiety disorder comorbidity: a randomized, single-blind, pilot study.
Maina G; Albert U; Rosso G; Bogetto F
J Clin Psychiatry; 2008 Apr; 69(4):609-16. PubMed ID: 18294024
[TBL] [Abstract][Full Text] [Related]
13. Mortality risk and mood stabilizers in bipolar disorder: a propensity-score-weighted population-based cohort study in 2002-2018.
Chan JKN; Wong CSM; Fang CZ; Hung SC; Lo HKY; Chang WC
Epidemiol Psychiatr Sci; 2024 May; 33():e31. PubMed ID: 38779809
[TBL] [Abstract][Full Text] [Related]
14. Management options for bipolar disorder in children and adolescents.
Danielyan A; Kowatch RA
Paediatr Drugs; 2005; 7(5):277-94. PubMed ID: 16220995
[TBL] [Abstract][Full Text] [Related]
15. Quetiapine and classical mood stabilizers in the long-term treatment of Bipolar Disorder: a 4-year follow-up naturalistic study.
Altamura AC; Mundo E; Dell'Osso B; Tacchini G; Buoli M; Calabrese JR
J Affect Disord; 2008 Sep; 110(1-2):135-41. PubMed ID: 18329720
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic treatment response in bipolar disorder: results of a naturalistic observation study.
Garnham J; Munro A; Slaney C; Macdougall M; Passmore M; Duffy A; O'Donovan C; Teehan A; Alda M
J Affect Disord; 2007 Dec; 104(1-3):185-90. PubMed ID: 17442400
[TBL] [Abstract][Full Text] [Related]
17. Revised Korean medication algorithm for bipolar disorder.
Jon DI; Bahk WM; Yoon BH; Shin YC; Cho HS; Lee E; Ha K; Kim W; Chung SK; Seo JS; Min KJ
World J Biol Psychiatry; 2009; 10(4 Pt 3):846-55. PubMed ID: 18615367
[TBL] [Abstract][Full Text] [Related]
18. Comparing adherence to and persistence with antipsychotic therapy among patients with bipolar disorder.
Hassan M; Madhavan SS; Kalsekar ID; Makela EH; Rajagopalan K; Islam S; Kavookjian J; Miller LA
Ann Pharmacother; 2007 Nov; 41(11):1812-8. PubMed ID: 17925501
[TBL] [Abstract][Full Text] [Related]
19. Alternatives to lithium and divalproex in the maintenance treatment of bipolar disorder.
Gnanadesikan M; Freeman MP; Gelenberg AJ
Bipolar Disord; 2003 Jun; 5(3):203-16. PubMed ID: 12780874
[TBL] [Abstract][Full Text] [Related]
20. Mortality risk with the use of atypical antipsychotics in later-life bipolar disorder.
Bhalerao S; Seyfried LS; Kim HM; Chiang C; Kavanagh J; Kales HC
J Geriatr Psychiatry Neurol; 2012 Mar; 25(1):29-36. PubMed ID: 22467844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
